SkinnyRx logo

SkinnyRx Review

7.6
★★★★☆3.8/5

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.6/10

Best for: compounded semaglutide or tirzepatide with the consult and free overnight shipping in one price

SkinnyRx scores highest on the strength of its clinical program: drug options and dosing support.

Offer67%Off 1st mo

SkinnyRx discount & current deal

Tirzepatide injection$99/mo was$299

First month, then $299/mo

Semaglutide

$99/mo · intro price

Tirzepatide

$99/mo · first month

then $299/mo ongoing

Price checked on SkinnyRx’s site,

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not stated

Coaching

Not stated

Get the $99/mo deal →

No insurance neededVetted by our editors

PartnerSkinnyRx is a partner: we may earn a commission if you sign up through our links. It doesn't affect the score. How we make money

Telehealth weight-loss provider offering compounded semaglutide and tirzepatide (weekly injections with a microdosing option, or once-daily tablets) and brand-name Ozempic, Mounjaro and Zepbound, prescribed by licensed US clinicians, with the consult and free overnight shipping bundled into a monthly cash price.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedSemaglutideTirzepatide

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

SkinnyRx logo
3.8 / 5
Our editorial rating
Visit SkinnyRx →

from $299/mo (after intro offer) · no insurance needed

SkinnyRx at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$299/mo (after intro offer) ($99 first month)
What's included
Medication · Consult · Shipping
FDA status
1 FDA warning letter on record; see below

How we scored SkinnyRx

Each dimension is scored algorithmically from SkinnyRx’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

6.5/10

At $299/mo (after intro offer), SkinnyRx runs about 67% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).

Effectiveness25%

9.5/10

SkinnyRx offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions. An oral/needle-free option is offered for patients who avoid injections.

User Experience15%

8.1/10

Online intake and platform experience (consult included in the price); 3 platform features disclosed.

Trust & Safety15%

6.3/10

Core details confirmed by our editors; an FDA warning letter is on file (see flag above).

Accessibility10%

7.1/10

SkinnyRx's exact state footprint isn't published. Confirm coverage in your state before signing up.

Support10%

6.9/10

SkinnyRx provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
671providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this SkinnyRx review

Last checked November 2026
  • Confirmed current pricing across 9 dose/plan tiers
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$99–$1,400/mo across 9 dose/plan tiers (checked November 2026)
FDA warning-letter register
An active letter is on file for this provider; see below

What to expect when you sign up with SkinnyRx

We walked SkinnyRx’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Complete the online medical intake questionnaire.
  2. 2A licensed clinician reviews your information; based on your state, you may have a quick video visit or receive a prescription directly within 24 hours.
  3. 3After the prescription is written, medication is processed and you receive shipping/tracking within 2 business days.
  4. 4Each month you fill out a refill form to continue, with unlimited portal access to the care team.
Price shown before you start
  • First-month prices are shown on the public pages for every compounded product, and full plan prices for tirzepatide; the ongoing semaglutide price is not. Payment is processed only after completing the pre-qualification intake.
  • Full refund available any time before a provider completes the prescription review; non-refundable once fulfillment begins; future months can be canceled anytime.
  • You won't be charged if the provider deems you ineligible (full refund within 24-48 hours).
  • No insurance required; accepts all major credit cards and FSA/HSA cards.
  • Ships with tracking within 2 business days; unlimited clinician consults via the portal at no extra cost.

SkinnyRx customer support

GLP-1 medications SkinnyRx offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

Peptides SkinnyRx offers

Beyond GLP-1s, SkinnyRx also offers these peptides. Tap any for our evidence-based guide.

Pricing

Prices re-verified

Injection, first month (ongoing monthly rate not published)Compounded
$99/mo
semaglutide

SkinnyRx advertises “$99 first month” for compounded injectable semaglutide, with a microdose option and free overnight shipping. The price from month two is not shown on the public site.

Once-daily tablets, first month (ongoing monthly rate not published)Compounded · oral
$149/mo
semaglutide

SkinnyRx advertises “$149 first month” for compounded semaglutide tablets. The price from month two is not shown on the public site.

Weekly injection, 1-month planCompounded
$299$99/mo
Save 67% right now
tirzepatide

$99 first month, then $299/mo on the 1-month plan; $289/mo on 4 months, $250 on 6, $225 on 12, each with the same $99 first month. The $99 offer runs “While Supplies Last.” Microdose available; free overnight shipping.

Once-daily tablets, 1-month planCompounded · oral
$299$199/mo
Save 33% right now
tirzepatide

$199 first month, then $299/mo on the 1-month plan; $289/mo on 3 months, $250 on 6, $225 on 12, each with the same $199 first month. Microdose available.

Ozempic monthly planBrand-name
$1,400/mo
semaglutide (ozempic)

Listed at '$1,400/mo*'. The asterisk reads: '*Price shown applies to Monthly plan paid upfront or with buy now, pay later programs.' The page adds: 'No membership fees. Same price at every dose.'

Wegovy pill, once dailyBrand-name
$248/mo
semaglutide (wegovy pill)

Listed “From $248/month” and “available via SkinnyRx Membership.” The page does not say whether $248 includes the medication. The Wegovy injection is no longer listed.

Mounjaro monthly planBrand-name
$1,400/mo
tirzepatide (mounjaro)

Listed at '$1,400/mo*'. The page adds: 'No membership fees. Same price at every dose.'

Zepbound monthly planBrand-name
$1,400/mo
tirzepatide (zepbound)

Listed at '$1,400/mo*'. The page adds: 'No membership fees. Same price at every dose.'

Foundayo pill, once dailyBrand-name
$248/mo
orforglipron (foundayo)

Listed “From $248/month” and “available via SkinnyRx Membership.” The page does not say whether $248 includes the medication.

Ready to get started?

Plans and promotions change often, so check SkinnyRx's current pricing and active discounts before you decide.

See SkinnyRx pricing →

What we like

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access
  • $99 first month on compounded injections; tirzepatide plans are published, from $299/mo month-to-month down to $225/mo on a 12-month plan
  • Licensed US clinicians on every prescription
  • Free overnight shipping included; the 1-month plan can be canceled anytime

Watch-outs

  • Only a first-month price is published for semaglutide; the ongoing rate is not shown on the public site
  • Certain compounded medications are not available in Alabama, Louisiana or Mississippi, and the Terms don't say that list is complete
  • Bundled multi-month plans are non-refundable, and canceling before a promotional or committed term ends can reverse the discount

SkinnyRx in one line: cheap, broad GLP-1 access with a 2026 FDA warning letter

SkinnyRx, operated by Lean Rx, Inc., is a mainstream telehealth front-end for compounded GLP-1 weight-loss medication. It covers what most people in the market want. It offers both semaglutide and tirzepatide, it folds the clinician visit and shipping into the price, and it lands well under the brand-name pens that can run more than a thousand dollars a month elsewhere. Weigh one fact before anything else: SkinnyRx received an FDA warning letter in early 2026. That doesn't make the medication unusable, but it changes how much benefit of the doubt the company has earned. The letter's details are below.

How the pricing works

SkinnyRx prices everything around a first-month offer. Compounded injections start at $99 for the first month, and tirzepatide then runs $299 per month (after intro offer) on the 1-month plan, with lower monthly rates on 4-, 6- and 12-month plans. That figure is meant to be all-in: the medication, the clinician consult through the patient portal, and shipping are bundled, so you're not nickel-and-dimed by a separate visit charge the way some providers do it. Semaglutide is less clear. The site shows only its first-month price, not what you pay from month two. Treat the first-month number as a starting cost, not your steady one.

For context, the category median across the providers we track sits near $179 per month, so SkinnyRx's month-to-month tirzepatide rate sits above the middle of the pack. Longer plans bring it down, but they come with strings. The product pages say plans can be canceled at any time, yet the site also says bundled subscriptions are non-refundable, and canceling before a promotional or committed term ends can reverse the discount you got. If you might stop or switch medication, the 1-month plan is the safer buy.

How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.

The medications and how they reach you

You can get compounded semaglutide (the molecule in Ozempic and Wegovy) or compounded tirzepatide (the molecule in Mounjaro and Zepbound), as a weekly injection or a once-daily tablet. Having both on the menu is useful, because tirzepatide tends to drive larger losses for many people, and not every budget provider stocks it. These are compounded versions, not the FDA-approved branded pens, which is how the price gets down to this level. SkinnyRx also lists brand-name Ozempic, Mounjaro and Zepbound at $1,400 a month, and the Wegovy and Foundayo pills from $248 a month through a separate membership. Every prescription is written by a licensed U.S. clinician, the consult happens inside the patient portal at no extra cost, and the medication ships discreetly to your door with free overnight delivery advertised on orders.

  • Compounded semaglutide: the lower-cost option for appetite control and steady weight loss
  • Compounded tirzepatide: the dual-action option many people step up to for stronger results
  • Once-daily tablets: compounded semaglutide or tirzepatide for people who would rather skip the needle
  • The clinician consult is handled through the portal, with no separate visit fee
  • Overnight shipping is free rather than added at checkout

The FDA warning letter: what it says and why it matters

In February 2026 the FDA issued a warning letter (number 717989) to Lean Rx, Inc., doing business as SkinnyRx. The main finding was that the labeling pictured on the company's website for its compounded semaglutide and tirzepatide put the "SkinnyRx" name on the product label in a way that implies SkinnyRx is the compounder when it is not. The letter also cited additional false or misleading claims under the federal misbranding rules. You can read our full breakdown on the SkinnyRx FDA warning letter page.

This is a labeling-and-marketing citation. It is not a recall, and it is not a finding that the medicine itself is contaminated or dangerous. But it tells you the company was willing to present itself as the maker of a product it doesn't compound, and it does not name the accredited pharmacy filling the prescriptions. SkinnyRx discloses no compounding partner, which is a transparency gap on its own. A warning letter on top of that gap is the kind of signal a careful shopper should not wave away.

Where SkinnyRx is thin: transparency

Beyond the FDA matter, SkinnyRx still leaves gaps before you hand over information. Its Terms now say certain compounded medications are not available in Alabama, Louisiana or Mississippi, while brand-name medication may be available in every state. The word "certain" means that list may not be the whole story, so confirm your state inside the intake. Tirzepatide plan prices are posted, but semaglutide shows only a first-month price, and the pharmacy that fills your order is never named. None of that is disqualifying, but it means you're asked to trust first and ask questions later, which is the opposite of how a medical purchase should go.

Who should consider it, and who should skip it

SkinnyRx makes the most sense for a price-driven shopper who wants both semaglutide and tirzepatide on one platform, with the consult and shipping baked into a single monthly number. That shopper also has to be comfortable doing their own due diligence on a company carrying a recent FDA flag. The month-to-month plan and bundled pricing are conveniences for that buyer.

Skip it if you want maximum transparency and a clean compliance record. Sprout Health, for example, names the two pharmacies that ship its compounded medication. If you'd feel uneasy not knowing which pharmacy compounds your medication, or you want a provider that publishes its full service area and every price up front, you have lower-risk options at a similar price. Midlife women who'd rather have a GLP-1 managed inside menopause care can look at Midi Health, which also accepts commercial insurance. If you want brand-name Zepbound or Ozempic, SkinnyRx sells them, but at $1,400 a month you should compare its price against other brand-name sellers first.

Bottom line

SkinnyRx offers both major GLP-1 molecules as injections or tablets, U.S. clinicians, all-in tirzepatide pricing of $299 a month (after intro offer) on the 1-month plan, free overnight shipping, and a $99 first month on injections. Trust keeps it out of our top tier. A 2026 FDA warning letter over misleading labeling, an undisclosed compounding pharmacy, an unpublished semaglutide price, and non-refundable bundled plans add up to a transparency problem you should weigh seriously. If price and drug selection are your only criteria, it's a reasonable pick. If oversight and disclosure matter to you, read the warning-letter details first and compare against cleaner-record providers using our scoring methodology before you commit.

The Bottom Line

SkinnyRx scores highest on the strength of its clinical program: drug options and dosing support.

Score: 7.6/10Best for: compounded semaglutide or tirzepatide with the consult and free overnight shipping in one priceFrom: $299/mo (after intro offer)

Ready to start with SkinnyRx?

From $299/mo (after intro offer). See current pricing and start your free consultation.

SkinnyRx might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If the lowest possible monthly price is your top priority, consider altRX (from $89/mo).
  • If you want built-in coaching and behavior-change support, consider Ro.

Alternatives to SkinnyRx

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
“starting at” price
$129/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →

Head-to-head

Compare SkinnyRx vs…

SkinnyRx scores7.6/10

Side-by-side pricing, medications and scores. Pick a matchup.

All 45 SkinnyRx comparisons

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

SkinnyRx is a telehealth GLP-1 prescribing platform with licensed U.S. clinicians, a free clinical consultation, and free overnight shipping. However, in February 2026 the FDA issued a warning letter to Lean Rx, Inc. dba SkinnyRx, citing false and misleading claims in website labeling for compounded semaglutide and tirzepatide. Specifically, the labeling implied SkinnyRx itself was the compounder when it is not. The letter also cited additional violations under the Federal Food, Drug, and Cosmetic Act. We recommend reviewing the full FDA warning letter at fda.gov and confirming that the identified issues have been resolved before enrolling. Patients are encouraged to ask SkinnyRx's support team directly about their current compliance status and pharmacy partners.
SkinnyRx is an online telehealth platform (legal name Lean Rx, Inc.) that connects patients with licensed clinicians to prescribe compounded GLP-1 medications for weight loss. The service is fully digital (no in-person visits required) and provides access to compounded semaglutide and compounded tirzepatide (injections or once-daily tablets), plus brand-name Ozempic, Mounjaro and Zepbound, shipped discreetly to your home. A clinical consultation is included at no extra charge through the patient portal, and free overnight shipping is part of the subscription. Its Terms say brand-name medication may be available in all U.S. states, while certain compounded medications are not available in Alabama, Louisiana or Mississippi.
SkinnyRx prices its compounded medication around a first-month offer: $99 for injectable semaglutide or tirzepatide, $149 for semaglutide tablets and $199 for tirzepatide tablets. After that, compounded tirzepatide (injection or tablets) costs $299 a month on the 1-month plan, less on longer plans, down to $225 a month on a 12-month plan. The ongoing semaglutide price is not shown on the public site. Brand-name Ozempic, Mounjaro and Zepbound are listed at $1,400 a month, and the Wegovy and Foundayo pills from $248 a month through a SkinnyRx Membership. Confirm the price from month two before you pay, and note that multi-month bundles are non-refundable.
SkinnyRx is a telehealth prescribing platform, not a drug, so the FDA approval question applies to the medications it dispenses. The medications prescribed through SkinnyRx (compounded semaglutide and compounded tirzepatide) are not FDA-approved finished drug products. They are prepared by third-party licensed compounding pharmacies per individual prescription and are not pre-market reviewed by the FDA for safety, efficacy, or quality on a batch-by-batch basis. The active ingredients are the same GLP-1 compounds studied in clinical trials, but compounded formulations may differ from brand-name products in inactive ingredients. In February 2026, the FDA also issued SkinnyRx a warning letter for labeling violations related to how its compounded products were presented on its website.
The compounded semaglutide and tirzepatide prescribed through SkinnyRx are not appropriate for everyone. Standard contraindications for GLP-1 medications include a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), active or recent pancreatitis, current pregnancy or breastfeeding, and severe hypersensitivity to the active ingredient. Patients with certain gastrointestinal disorders, severe kidney or liver disease, or those taking medications that interact with GLP-1 agonists should discuss these factors with the prescribing clinician. SkinnyRx's intake questionnaire is designed to screen for these contraindications, but the final prescribing decision rests with your assigned licensed clinician based on your full health history.
A SkinnyRx subscription includes the compounded medication, a free clinical consultation through the patient portal (at no extra charge), and free overnight shipping on all orders. No additional fees are disclosed for the provider visit. Prescription refills are managed through the online portal, and your clinician can adjust your plan as needed. Behavioral coaching and structured nutrition support are not listed as included benefits in the publicly available program details. SkinnyRx does not publicly disclose the name of its compounding pharmacy partner(s). If this matters to you, ask their support team before completing your intake.
SkinnyRx doesn't require a coupon code. New patients currently get an intro price of $99/mo for the first month (then $299/mo), applied automatically through the link on this page. Third-party "SkinnyRx promo code" sites are typically fake; the real offer is on SkinnyRx's checkout.
The main red flag is an FDA warning letter on file, which this review flags. Read it before starting. We also note: Only a first-month price is published for semaglutide; the ongoing rate is not shown on the public site; Certain compounded medications are not available in Alabama, Louisiana or Mississippi, and the Terms don't say that list is complete; Bundled multi-month plans are non-refundable, and canceling before a promotional or committed term ends can reverse the discount.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Regulatory notice

SkinnyRx received an FDA warning letter dated February 20, 2026

The letter concerns false & misleading claims/misbranded. FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity. Companies often respond with corrective action.

Read the full letter →

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this SkinnyRx review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See SkinnyRx's current pricing

Plans from $299/mo (after intro offer). Start your free consultation to check eligibility and today's price.